Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Arshi Lehal

Oral & Maxillofacial Surgery Warren, MI Medical Doctor

NPI 1720341886 CMS profile 583200

29427 Ryan Rd, Warren, MI 48092

Open in the dashboard

General payments

$3,223

30 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Arshi Lehal of Warren, MI is reported in the CMS Open Payments database as having received $3,223 across 30 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 76th percentile of Oral & Maxillofacial Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,130 19
2024 General $823 8
2019 General $271 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Arshi Lehal
  • Oral & Maxillofacial Surgery median
  • Middle half of Oral & Maxillofacial Surgery
  • National median

In program year 2025, general payments to Arshi Lehal were reported at $2,130. Among 792 Oral & Maxillofacial Surgery profiles paid that year, the median was $184 and the middle half received between $61 and $541.

Show as a table
Year Arshi Lehal Oral & Maxillofacial Surgery median Middle half National median
2019 $271 $178 $56–$584 $163
2020 $0 $106 $38–$316 $114
2021 $0 $165 $57–$511 $132
2022 $0 $173 $63–$494 $149
2023 $0 $184 $62–$521 $160
2024 $823 $197 $65–$603 $164
2025 $2,130 $184 $61–$541 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Zimvie Inc. $2,424 23 payments
  2. Stryker Corporation $280 2 payments
  3. AxoGen $263 2 payments
  4. KLS-Martin L.P. $167 2 payments
  5. Straumann USA LLC $90 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $1,853 10 payments
  2. Food and Beverage $1,370 20 payments
Products named General payments · program years 2019–2025
  1. Tapered Screw-Vent $2,133 15 payments
  2. NA Neuro $280 2 payments
  3. VSP SYSTEM, VSP CRANIAL $270 2 payments
  4. TSX Implants $267 7 payments
  5. AxoGuard Nerve Connector $263 2 payments
  6. AXOGUARD NERVE PROTECTOR $263 2 payments
  7. NA Craniomaxillofacial $144 1 payment
  8. SMARTLOCK $144 1 payment
  9. PATIENT-FITTED TMJ RECONSTRUCTIVE PROSTHESIS SYSTEM $144 1 payment
  10. MEDPOR TITAN $144 1 payment
  11. Other $295 3 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

739

Median for Maxillofacial Surgery: 343

Drug cost

$2,137

Median for Maxillofacial Surgery: $1,437

Branded share of claims

21.8%

Median for Maxillofacial Surgery: 21.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Chlorhexidine Gluconate Generic 200 $842
Amoxicillin Generic 233 $463
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 11 $201
Ibuprofen Generic 92 $200
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 105 $196
Clindamycin Hcl Generic 40 $130
Acetaminophen-Codeine Acetaminophen With Codeine Brand 29 $66
Ibu Ibuprofen Brand 16 $30
Tramadol Hcl Generic 13 $9

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 692 Part D prescribers listed as Maxillofacial Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 28 billing codes

Paid by Medicare

$13,293

Medicare's payments for the services billed

Medicare patients

50

Average age 70

Services billed

101

39 women, 11 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 64%
Arthritis 46%
Depression 30%
Diabetes 26%
Ischemic heart disease 26%
Alzheimer's or dementia 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

30 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Oral & Maxillofacial Surgery in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record